Generation Bio Co (GBIO) Stock: Evaluating the Market Performance

Moreover, the 36-month beta value for GBIO is 2.78. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for GBIO is 48.54M and currently, short sellers hold a 2.35% of that float. On April 17, 2024, GBIO’s average trading volume was 250.42K shares.

GBIO) stock’s latest price update

Generation Bio Co (NASDAQ: GBIO)’s stock price has dropped by -15.41 in relation to previous closing price of 3.70. Nevertheless, the company has seen a loss of -21.36% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-06 that Generation Bio Co. (GBIO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.55 per share a year ago.

GBIO’s Market Performance

Generation Bio Co (GBIO) has seen a -21.36% fall in stock performance for the week, with a 1.29% gain in the past month and a 73.89% surge in the past quarter. The volatility ratio for the week is 11.77%, and the volatility levels for the past 30 days are at 9.98% for GBIO. The simple moving average for the past 20 days is -15.31% for GBIO’s stock, with a 3.26% simple moving average for the past 200 days.

Analysts’ Opinion of GBIO

Canaccord Genuity, on the other hand, stated in their research note that they expect to see GBIO reach a price target of $9. The rating they have provided for GBIO stocks is “Buy” according to the report published on November 08th, 2022.

GBIO Trading at 7.04% from the 50-Day Moving Average

After a stumble in the market that brought GBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.16% of loss for the given period.

Volatility was left at 9.98%, however, over the last 30 days, the volatility rate increased by 11.77%, as shares surge +5.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +70.11% upper at present.

During the last 5 trading sessions, GBIO fell by -21.36%, which changed the moving average for the period of 200-days by -37.65% in comparison to the 20-day moving average, which settled at $3.70. In addition, Generation Bio Co saw 89.70% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GBIO starting from Samayoa Phillip, who sale 2,445 shares at the price of $1.62 back on Jan 02 ’24. After this action, Samayoa Phillip now owns 107,256 shares of Generation Bio Co, valued at $3,961 using the latest closing price.

Paone Antoinette, the CHIEF OPERATING OFFICER of Generation Bio Co, sale 2,445 shares at $1.62 during a trade that took place back on Jan 02 ’24, which means that Paone Antoinette is holding 5,828 shares at $3,961 based on the most recent closing price.

Stock Fundamentals for GBIO

Current profitability levels for the company are sitting at:

  • -23.47 for the present operating margin

The net margin for Generation Bio Co stands at -20.75. The total capital return value is set at -0.41. Equity return is now at value -52.14, with -33.72 for asset returns.

Based on Generation Bio Co (GBIO), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at -0.54. The debt to equity ratio resting at 0.48. The interest coverage ratio of the stock is -11.59.

Currently, EBITDA for the company is -133.3 million with net debt to EBITDA at -0.23. When we switch over and look at the enterprise to sales, we see a ratio of 40.57. The receivables turnover for the company is 1.42for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.83.

Conclusion

To wrap up, the performance of Generation Bio Co (GBIO) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts